Travis Dunckley
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$3.9MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $3.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 14, 2025 | NIH | SBIR Phase II Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome | $1.4M | ILUMINOS THERAPEUTICS LLC |
| Sep 17, 2024 | NIH | SBIR Phase II Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome | $1.5M | ILUMINOS THERAPEUTICS LLC |
| Sep 15, 2022 | NIH | STTR Phase I Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome | $499K | ILUMINOS THERAPEUTICS LLC with ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
| Sep 13, 2022 | NIH | STTR Phase II Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome | $499K | ILUMINOS THERAPEUTICS LLC |
Peer ranks
Federal funding#409
Awards as PI#566
Patents#273
Companies
- ILUMINOS THERAPEUTICS LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.